Previous Issues

Newsletter Archive

In This Issue

• Join the Experts for a Half-Day Seminar on Pharmaceutical Water & Steam - Read the full story . . .
• Prepare for CPIP Certification - Join the Chapter's Spring Study Group - Read the full story . . .
• Calling All Student Members... - Read the full story . . .
• Bio-Ball Needs Chapter Member Volunteers on April 28th - Read the full story . . .
• Want to Become a Chapter Sponsor? It's Easy! - Read the full story . . .
• Scholarship Program for Chapter Members - Next Deadline June 15 - Read the full story . . .

Pool sharks, food and drink, and lively conversation - the Chapter's annual Holiday Social had it all, including a chance to contribute to a worthy charitable cause...

• Genzyme's Framingham Work Clears Europe Hurdle - Read the full story . . .
• MetroWest Firm Roadmaps Human Genome - Read the full story . . .
• Life Technologies in Race to Introduce $1000 Gene Map - Read the full story . . .
• Drug Maker Cubist Plans Suit over Would-Be Generic - Read the full story . . .
• Bristol-Myers Squibb to Acquire Inhibitex for $2.5 Billion - Read the full story . . .
• Sanofi Says It Will Trim $170m in Annual Costs - Read the full story . . .
• Takeda Pharmaceutical to Cut 150 Chicago-Area Jobs - Read the full story . . .
• Eye Study is First Involving Human Stem Cells - Read the full story . . .
• AstraZeneca Plans to Cut 7,300 Jobs - Read the full story . . .
• With $32.5 Million Gift, Broad Institute to Open  - Read the full story . . .
• Amylin, Alkermes get OK for diabetes drug - Read the full story . . .
• Novartis Job Cuts Spare Cambridge - Read the full story . . .

• FDA Expands Use of Merck's HIV Drug Isentress to Children and Adolescents - Read the full story . . .
• FDA Expands Use of Wyeth's Prevnar 13 Vaccine for People 50 and Older - Read the full story . . .
• FDA Completes Work on Drug User Fee Programs - Read the full story . . .
• FDA and Industry Reach Agreement on Medical Device User Fees - Read the full story . . .
• FDA Permits Marketing of First Test for Risk of Rare Brain Infection in Some People Treated With Tysabri - Read the full story . . .
• FDA Approves Pfizer's Inlyta for Patients with Type of Advanced Kidney Cancer - Read the full story . . .
• FDA Approves Genentech Drug for Most Common Type of Skin Cancer - Read the full story . . .
• FDA Approves Vertex Drug Kalydeco to Treat Rare Form of Cystic Fibrosis - Read the full story . . .
• FDA Approves Gleevec for Use in Patients with Rare Gastrointestinal Cancer - Read the full story . . .
• FDA Issues Draft Guidance on Biosimilar Product Development - Read the full story . . .
• Bristol-Myers Squibb and AstraZeneca Receive FDA Complete Response Letter for Dapagliflozin - Read the full story . . .